The following Appendix 4D and Half-Year Report has been lodged with ASX.
Read Appendix 4D and Half-Year Report.
Quarterly Activity Report – Quarter ending 31 December 2023
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal